BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, December 18, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for April 3, 2020

April 3, 2020
New hires and promotions in the med-tech industry, including: Kaleido Biosciences, Stimwave Technologies.
Read More

Regulatory actions for April 3, 2020

April 3, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cytodyn, Gracell, I-Mab, Iveric, Novan, Revive.
Read More

Other news to note for April 3, 2020

April 3, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: American Cryostem, Aradigm, Brainstorm, Capricor, Celltrion, Emergent, Grifols, GSK, Icagen, Incyte, Innate, Innovax, Ligand, Neurocrine, Novartis, Regenerx, Ridgeback, Savara, Seneca, Siga, Sumitomo, Voltron.
Read More

In the clinic for April 3, 2020

April 3, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Axon, Denali, Neurocrine, Novan, Oryzon, Regeneron, Restorbio, Sanofi, Umecrine, Urogen, Voyager.
Read More

Financings for April 3, 2020

April 3, 2020
Biopharmas raising money in public or private financings, including: Oncology Venture, Phio, Vivus.
Read More

Appointments and advancements for April 3, 2020

April 3, 2020
New hires and promotions in the biopharma industry, including: Kaleido, Kodiak, Lumos.
Read More

Regulatory actions for April 2, 2020

April 2, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allergan, Braintale, Outset Medical, Orthopediatrics, Royal Philips, Sectra, Tissium, Won Tech.
Read More

Other news to note for April 2, 2020

April 2, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Amarex, Amra Medical, Auburn University, Biomerica, BCBS of Massachusetts, Cytodyn, CDx Diagnostics, Cerus, CHF Solutions, Element, Enicor, Evotec, Eyetech Digital Systems, Foracare, Gerber Technology, GN Hearing, Haemonetics, Hardwire, Hong Kong Polytechnic University, Imaging Endpoints, Innovo Research, Jolly Good, Lantheus Holdings, Leap Therapeutics, Microgendx Laboratories, Misonix Inc., Nanomosaic, Nanovibronix, Pancella, Progenics Pharmaceuticals, Promega, Sanuwave Health, Science 37, Sensor Electronic Technology, Seoul Viosys, Siemens Healthineers, Vericel.
Read More

In the clinic for April 2, 2020

April 2, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Natera, Sightglass Vision.
Read More

Financings for April 2, 2020

April 2, 2020
Med-tech firms raising money in public or private financings, including: Cooper Companies, Invitae, Medgenome, Nevro.
Read More
Previous 1 2 … 1573 1574 1575 1576 1577 1578 1579 1580 1581 … 1718 1719 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 17, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 17, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing